glp-1 agonists for weight loss pills Comparing Ozempic, Wegovy and Other Drugs Part 2 of a 3-Part

Their mechanism of action involves several complementary pathways: Enhancing glucose-dependent insulin secretion from pancreatic beta cells, which helps lower blood glucose levels when they are elevated Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which moderates the rate at which nutrients enter the bloodstream Promoting satiety through central nervous system effects, leading to reduced appetite and caloric intake These combined effects result in improved glycaemic control in people with type 2 diabetes and significant weight loss in those using higher doses for obesity management

Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD): pathways of action of hypoglycemic agents

2024, doi: 10.5603/cd.102035

doi: 10.7326/0003-4819-138-1-200301070-00008

Several studies found that GLP-1RAs might have direct effects on adipogenesis, lipotoxicity, fatty acid oxidation, cytokines related to hepatitis and fibrosis, and intestinal microbiota (193, 195)